Answers are grounded in this paper and cite their sources.
1 Malonyl-CoA decarboxylase in rat liver, heart, kidney and brain is mainly a mitochondrial enzyme associated with the matrix space. 2 The Michaelis constant for this enzyme, in rat liver mitochondria, has been calculated as 42 μM. 3 N-Ethylmaleimide, p-chloromercuribenzoate and palmityl-CoA, but not arsenite, inhibit malonyl-CoA decarboxylase. The inhibition by –SH group blocking reagents is prevented by β-mercaptoethanol and is competitive with respect to substrate malonyl-CoA. The inhibition by palmityl-CoA is an “uncompetitive” type. 4 [1,3-14C]Malonyl-CoA is incorporated at almost the same rate as [1-14C]acetyl-CoA into fatty acids by rat liver mitochondria. In both cases only chain elongation of endogenous fatty acids is observed. By making use of inhibitors of malonyl-CoA decarboxylase, clear evidence is obtained that malonyl-CoA is decarboxylated to acetyl-CoA before its incorporation into fatty acids by mitochondria. 5 At concentrations more than twice that which completely inhibit malonyl-CoA decarboxylase, p-chloromercuribenzoate and palmityl-CoA also inhibit fatty acid synthesis in rat liver mitochondria. 6 The possible physiological role of malonyl-CoA decarboxylase in cellular metabolism is discussed.
No takes yet. Share an insight, caveat, or question.
Landriscina et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: